Hims & Hers Health HIMS Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, Before Tax, Noncurrent

Other financials

Revenue$608.1M+3.8%

Gross profit$396.8M-7.9%

Operating income-$78.3M-235%

Net income-$92.1M-286%

EPS (diluted)-$0.40-300%

Cash & equivalents$222.3M-19.2%

Total debt$157.9M+149%

Total equity$446.2M-18.8%

Total assets$2.3B+154%

Operating cash flow$89.4M-18.1%

CapEx$8.8M-19.9%

Free cash flow$80.5M-17.9%

Market cap$8.21B-27.9%

Enterprise value$8.15B-26.5%

P/S3.5×-2.9×

Gross margin71.7%-5.3pp

Operating margin-1.3%-7.5pp

Net margin-0.6%-9.8pp

FCF margin11.9%-5.8pp

Return on equity-2.7%-39.4pp

Debt / equity0.4×+0.2×

Current ratio1.7×+0.1×

Reported directly by Hims & Hers Health in its filing.

Tagged under the XBRL concept hims:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent.

The official record: Hims & Hers Health’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is Hims & Hers Health's debt securities, available-for-sale, accumulated gross unrealized loss, before tax, noncurrent?: Hims & Hers Health (HIMS) reported debt securities, available-for-sale, accumulated gross unrealized loss, before tax, noncurrent of $3K in Q4 2025.